Edwards Lifesciences Receives CE Mark for SAPIEN XT System for Valve-In-Valve Procedures

by Kathy Jones on  February 7, 2014 at 9:07 PM Medical Gadgets
RSS Email Print This Page Comment
Font : A-A+

California-based Edwards Lifesciences Corporation revealed that it has received the CE Mark in Europe for the use of its valve-in-valve procedures using the SAPIEN XT transcatheter heart valve as a minimally invasive treatment option for patients who are at a high risk of surgery and who require a replacement of their surgical mitral or aortic valves.
 Edwards Lifesciences Receives CE Mark for SAPIEN XT System for Valve-In-Valve Procedures
Edwards Lifesciences Receives CE Mark for SAPIEN XT System for Valve-In-Valve Procedures

The company revealed that SAPIEN XT valve can reside on top of a previously installed prosthetic valve and is the only device that has been approved for valve-in-valve procedures inside the mitral valve

"The European approval of the SAPIEN XT system for valve-in-valve procedures is a milestone achievement. While this is not a large financial opportunity, it represents an important benefit for patients unable to go through a second open-heart surgery to replace their failing bioprosthetic valves", the company's corporate vice president, transcatheter heart valves, Larry Woods said.



Source: Medindia

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
Notify me when reply is posted
I agree to the terms and conditions

More News on:

Modified Atkins Diet: All You Need to Know 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

News Category

News Archive